[
 {
  "title": "mRNA technology is not new",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "Possibilities for synthetic mRNA have been the focus of decades-long scientific research. Pfizer-BioNTech and Moderna were able to produce their respective vaccines as quickly as they did because both companies had invested in research on mRNA-based treatments long before COVID-19 appeared on the scene.",
  "content_length": 304,
  "content_tokens": 61,
  "embedding": []
 },
 {
  "title": "Other RNA-based vaccine applications",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "RNA-based technology is used in a recent malaria vaccine patent and BioNTech uses the technology in its cancer immunotherapy research where the mRNA vaccine is individually adapted to target specific tumor mutations.",
  "content_length": 216,
  "content_tokens": 38,
  "embedding": []
 },
 {
  "title": "mRNA technology is not a panacea",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "The success of the mRNA technology used in COVID-19 vaccines does not guarantee success in other applications. In other words, the technology is not a panacea. It could be that SARS-CoV-2 is the perfect viral candidate, for a few reasons.",
  "content_length": 238,
  "content_tokens": 55,
  "embedding": []
 },
 {
  "title": "The Developmental History of mRNA Vaccine Strategy",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "The mRNA vaccine strategy itself, which was used in this case to code for the SARS-CoV-2 spike protein and instruct the immune system to recognize and respond against it, has an extensive developmental history paved with trials and failures.",
  "content_length": 241,
  "content_tokens": 48,
  "embedding": []
 },
 {
  "title": "Failures to Produce an HIV Vaccine Led to Innovative Advances",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "One editorial contends that the failures to produce an HIV vaccine were neither a waste of time nor economic resources because they propelled innovative advances which led to effective antiviral vaccines like the one for COVID-19.",
  "content_length": 230,
  "content_tokens": 41,
  "embedding": []
 },
 {
  "title": "Failed HIV Vaccines Laid the Foundational Understanding for COVID-19 mRNA Vaccines",
  "date": "April 11, 2021",
  "context": "COVID-19",
  "people": "Peter Attia",
  "content": "More specifically, a line of research from failed HIV vaccines laid the foundational understanding for the vaccine model that uses a purified viral protein, as in the case of COVID-19 mRNA vaccines.",
  "content_length": 198,
  "content_tokens": 38,
  "embedding": []
 }
]